Selected research
Market Structure
Global Arteriovenous Fistula Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Arteriovenous Fistula Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Arteriovenous Fistula Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Arteriovenous Fistula Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Arteriovenous Fistula Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Arteriovenous Fistula Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Arteriovenous Fistula Treatment include Teleflex Incorporated, Medtronic, Fresenius Medical Care AG & Co. KGaA, B. Braun Melsungen Ag, Poly Medicure Limited, NxStage Medical, Cook Medical and Becton Dickinson, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Arteriovenous Fistula Treatment market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Arteriovenous Fistula Treatment and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Arteriovenous Fistula Treatment revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Arteriovenous Fistula Treatment market size, projected growth trends, production technologies, key applications, and end-use industries.
Arteriovenous Fistula Treatment Segment by Company
Teleflex Incorporated
Medtronic
Fresenius Medical Care AG & Co. KGaA
B. Braun Melsungen Ag
Poly Medicure Limited
NxStage Medical
Cook Medical
Becton Dickinson
Arteriovenous Fistula Treatment Segment by Type
Peripheral Arteriovenous Fistulas
Dural Arteriovenous Fistulas
Pial or Cerebral Arteriovenous Fistulas
Arteriovenous Fistula Treatment Segment by Application
Drugs
Surgery
Transcatheter Embolization
Ultrasound-guided Compression
Arteriovenous Fistula Treatment Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Arteriovenous Fistula Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Arteriovenous Fistula Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Arteriovenous Fistula Treatment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Arteriovenous Fistula Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Arteriovenous Fistula Treatment industry.
Chapter 3: Detailed analysis of Arteriovenous Fistula Treatment companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Arteriovenous Fistula Treatmentrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Peripheral Arteriovenous Fistulas
- Dural Arteriovenous Fistulas
- Pial or Cerebral Arteriovenous Fistulas
Applications
- Drugs
- Surgery
- Transcatheter Embolization
- Ultrasound-guided Compression
Companies covered
- Teleflex Incorporated
- Medtronic
- Fresenius Medical Care AG & Co. KGaA
- B. Braun Melsungen Ag
- Poly Medicure Limited
- NxStage Medical
- Cook Medical
- Becton Dickinson
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Arteriovenous Fistula Treatment Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Peripheral Arteriovenous Fistulas
- 1.2.3 Dural Arteriovenous Fistulas
- 1.2.4 Pial or Cerebral Arteriovenous Fistulas
- 1.3 Market Analysis by Application
- 1.3.1 Global Arteriovenous Fistula Treatment Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Drugs
- 1.3.3 Surgery
- 1.3.4 Transcatheter Embolization
- 1.3.5 Ultrasound-guided Compression
- 1.4 Global Market Growth Prospects
- 1.5 Global Arteriovenous Fistula Treatment Growth Trends by Region
- 1.5.1 Global Arteriovenous Fistula Treatment Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Arteriovenous Fistula Treatment Market Size by Region (2021-2026)
- 1.5.3 Arteriovenous Fistula Treatment Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Arteriovenous Fistula Treatment Market Dynamics
- 2.1 Arteriovenous Fistula Treatment Industry Trends
- 2.2 Arteriovenous Fistula Treatment Industry Drivers
- 2.3 Arteriovenous Fistula Treatment Industry Opportunities and Challenges
- 2.4 Arteriovenous Fistula Treatment Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Arteriovenous Fistula Treatment Revenue by Company (2021-2026)
- 3.2 Global Arteriovenous Fistula Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Arteriovenous Fistula Treatment Key Company Head office and Area Served
- 3.4 Global Arteriovenous Fistula Treatment Company, Product Type & Application
- 3.5 Global Arteriovenous Fistula Treatment Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Arteriovenous Fistula Treatment Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Arteriovenous Fistula Treatment Players Market Share by Revenue in 2025
- 3.6.3 2025 Arteriovenous Fistula Treatment Tier 1, Tier 2, and Tier 3
4 Arteriovenous Fistula Treatment Market by Type
- 4.1 Global Arteriovenous Fistula Treatment Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Arteriovenous Fistula Treatment Market Size by Type (2021-2032)
- 4.3 Global Arteriovenous Fistula Treatment Market Size Share by Type (2021-2032)
5 Arteriovenous Fistula Treatment Market by Application
- 5.1 Global Arteriovenous Fistula Treatment Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Arteriovenous Fistula Treatment Market Size by Application (2021-2032)
- 5.3 Global Arteriovenous Fistula Treatment Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Teleflex Incorporated
- 6.1.1 Teleflex Incorporated Company Information
- 6.1.2 Teleflex Incorporated Business Overview
- 6.1.3 Teleflex Incorporated Arteriovenous Fistula Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Teleflex Incorporated Arteriovenous Fistula Treatment Product Portfolio
- 6.1.5 Teleflex Incorporated Recent Developments
- 6.2 Medtronic
- 6.2.1 Medtronic Company Information
- 6.2.2 Medtronic Business Overview
- 6.2.3 Medtronic Arteriovenous Fistula Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Medtronic Arteriovenous Fistula Treatment Product Portfolio
- 6.2.5 Medtronic Recent Developments
- 6.3 Fresenius Medical Care AG & Co. KGaA
- 6.3.1 Fresenius Medical Care AG & Co. KGaA Company Information
- 6.3.2 Fresenius Medical Care AG & Co. KGaA Business Overview
- 6.3.3 Fresenius Medical Care AG & Co. KGaA Arteriovenous Fistula Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Fresenius Medical Care AG & Co. KGaA Arteriovenous Fistula Treatment Product Portfolio
- 6.3.5 Fresenius Medical Care AG & Co. KGaA Recent Developments
- 6.4 B. Braun Melsungen Ag
- 6.4.1 B. Braun Melsungen Ag Company Information
- 6.4.2 B. Braun Melsungen Ag Business Overview
- 6.4.3 B. Braun Melsungen Ag Arteriovenous Fistula Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 B. Braun Melsungen Ag Arteriovenous Fistula Treatment Product Portfolio
- 6.4.5 B. Braun Melsungen Ag Recent Developments
- 6.5 Poly Medicure Limited
- 6.5.1 Poly Medicure Limited Company Information
- 6.5.2 Poly Medicure Limited Business Overview
- 6.5.3 Poly Medicure Limited Arteriovenous Fistula Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Poly Medicure Limited Arteriovenous Fistula Treatment Product Portfolio
- 6.5.5 Poly Medicure Limited Recent Developments
- 6.6 NxStage Medical
- 6.6.1 NxStage Medical Company Information
- 6.6.2 NxStage Medical Business Overview
- 6.6.3 NxStage Medical Arteriovenous Fistula Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 NxStage Medical Arteriovenous Fistula Treatment Product Portfolio
- 6.6.5 NxStage Medical Recent Developments
- 6.7 Cook Medical
- 6.7.1 Cook Medical Company Information
- 6.7.2 Cook Medical Business Overview
- 6.7.3 Cook Medical Arteriovenous Fistula Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Cook Medical Arteriovenous Fistula Treatment Product Portfolio
- 6.7.5 Cook Medical Recent Developments
- 6.8 Becton Dickinson
- 6.8.1 Becton Dickinson Company Information
- 6.8.2 Becton Dickinson Business Overview
- 6.8.3 Becton Dickinson Arteriovenous Fistula Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Becton Dickinson Arteriovenous Fistula Treatment Product Portfolio
- 6.8.5 Becton Dickinson Recent Developments
7 North America
- 7.1 North America Arteriovenous Fistula Treatment Market Size (2021-2032)
- 7.2 North America Arteriovenous Fistula Treatment Market Size by Type
- 7.2.1 North America Arteriovenous Fistula Treatment Market Size by Type (2021-2026)
- 7.2.2 North America Arteriovenous Fistula Treatment Market Size by Type (2027-2032)
- 7.2.3 North America Arteriovenous Fistula Treatment Market Share by Type (2021-2032)
- 7.3 North America Arteriovenous Fistula Treatment Market Size by Application
- 7.3.1 North America Arteriovenous Fistula Treatment Market Size by Application (2021-2026)
- 7.3.2 North America Arteriovenous Fistula Treatment Market Size by Application (2027-2032)
- 7.3.3 North America Arteriovenous Fistula Treatment Market Share by Application (2021-2032)
- 7.4 North America Arteriovenous Fistula Treatment Market Size by Country
- 7.4.1 North America Arteriovenous Fistula Treatment Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Arteriovenous Fistula Treatment Market Size by Country (2021-2026)
- 7.4.3 North America Arteriovenous Fistula Treatment Market Size by Country (2027-2032)
- 7.4.4 North America Arteriovenous Fistula Treatment Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Arteriovenous Fistula Treatment Market Size (2021-2032)
- 8.2 Europe Arteriovenous Fistula Treatment Market Size by Type
- 8.2.1 Europe Arteriovenous Fistula Treatment Market Size by Type (2021-2026)
- 8.2.2 Europe Arteriovenous Fistula Treatment Market Size by Type (2027-2032)
- 8.2.3 Europe Arteriovenous Fistula Treatment Market Share by Type (2021-2032)
- 8.3 Europe Arteriovenous Fistula Treatment Market Size by Application
- 8.3.1 Europe Arteriovenous Fistula Treatment Market Size by Application (2021-2026)
- 8.3.2 Europe Arteriovenous Fistula Treatment Market Size by Application (2027-2032)
- 8.3.3 Europe Arteriovenous Fistula Treatment Market Share by Application (2021-2032)
- 8.4 Europe Arteriovenous Fistula Treatment Market Size by Country
- 8.4.1 Europe Arteriovenous Fistula Treatment Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Arteriovenous Fistula Treatment Market Size by Country (2021-2026)
- 8.4.3 Europe Arteriovenous Fistula Treatment Market Size by Country (2027-2032)
- 8.4.4 Europe Arteriovenous Fistula Treatment Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Arteriovenous Fistula Treatment Market Size (2021-2032)
- 9.2 China Arteriovenous Fistula Treatment Market Size by Type
- 9.2.1 China Arteriovenous Fistula Treatment Market Size by Type (2021-2026)
- 9.2.2 China Arteriovenous Fistula Treatment Market Size by Type (2027-2032)
- 9.2.3 China Arteriovenous Fistula Treatment Market Share by Type (2021-2032)
- 9.3 China Arteriovenous Fistula Treatment Market Size by Application
- 9.3.1 China Arteriovenous Fistula Treatment Market Size by Application (2021-2026)
- 9.3.2 China Arteriovenous Fistula Treatment Market Size by Application (2027-2032)
- 9.3.3 China Arteriovenous Fistula Treatment Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Arteriovenous Fistula Treatment Market Size (2021-2032)
- 10.2 Asia Arteriovenous Fistula Treatment Market Size by Type
- 10.2.1 Asia Arteriovenous Fistula Treatment Market Size by Type (2021-2026)
- 10.2.2 Asia Arteriovenous Fistula Treatment Market Size by Type (2027-2032)
- 10.2.3 Asia Arteriovenous Fistula Treatment Market Share by Type (2021-2032)
- 10.3 Asia Arteriovenous Fistula Treatment Market Size by Application
- 10.3.1 Asia Arteriovenous Fistula Treatment Market Size by Application (2021-2026)
- 10.3.2 Asia Arteriovenous Fistula Treatment Market Size by Application (2027-2032)
- 10.3.3 Asia Arteriovenous Fistula Treatment Market Share by Application (2021-2032)
- 10.4 Asia Arteriovenous Fistula Treatment Market Size by Country
- 10.4.1 Asia Arteriovenous Fistula Treatment Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Arteriovenous Fistula Treatment Market Size by Country (2021-2026)
- 10.4.3 Asia Arteriovenous Fistula Treatment Market Size by Country (2027-2032)
- 10.4.4 Asia Arteriovenous Fistula Treatment Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Arteriovenous Fistula Treatment Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Arteriovenous Fistula Treatment Market Size by Type
- 11.2.1 South America, Middle East & Africa Arteriovenous Fistula Treatment Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Arteriovenous Fistula Treatment Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Arteriovenous Fistula Treatment Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Arteriovenous Fistula Treatment Market Size by Application
- 11.3.1 South America, Middle East & Africa Arteriovenous Fistula Treatment Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Arteriovenous Fistula Treatment Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Arteriovenous Fistula Treatment Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Arteriovenous Fistula Treatment Market Size by Country
- 11.4.1 South America, Middle East & Africa Arteriovenous Fistula Treatment Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Arteriovenous Fistula Treatment Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Arteriovenous Fistula Treatment Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Arteriovenous Fistula Treatment Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst